Halozyme Therapeutics has been granted a patent for an injection device designed to deliver medication to patients. The device features a syringe, needle guard, and locking mechanisms to ensure safe and effective administration of the medicament. GlobalData’s report on Halozyme Therapeutics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Halozyme Therapeutics, was a key innovation area identified from patents. Halozyme Therapeutics's grant share as of February 2024 was 52%. Grant share is based on the ratio of number of grants to total number of patents.
Injection device with safety features for medicament administration
See Also:
A recently granted patent (Publication Number: US11878156B2) discloses an injection device designed for administering medication to patients. The device comprises a housing with retaining arms and ribs, a syringe containing the medication, a needle, and a piston, all radially retained within the housing. Additionally, the device includes a needle guard, a ram with a rod connected to the piston, and a cap with an extension through the main spring. The device features an initial position where the retaining arm prevents the ram from firing, a released position allowing the ram to extend, and a locked position where the retaining arm and lock arm prevent the needle guard from retracting.
Furthermore, the patent details various configurations and components of the injection device, such as the design of the needle guard with windows for the retaining arm, the integration of retaining ribs into the housing, and the presence of lock arms on the ram. The device is specifically designed to include only essential components like the housing, syringe, needle, ram, needle guard, return spring, main spring, and cap. These features aim to provide a secure and efficient mechanism for injecting medication while ensuring the safety of both the patient and the user.
To know more about GlobalData’s detailed insights on Halozyme Therapeutics, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
